![Mark Sullivan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Sullivan
Gründer bei Medicines Development for Global Health Ltd
Aktive Positionen von Mark Sullivan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Medicines Development for Global Health Ltd
![]() Medicines Development for Global Health Ltd Pharmaceuticals: MajorHealth Technology Medicines Development Ltd. engages in the development of medicines and vaccines. Its development programs include Moxidectin Program, Global Health Programs, and Consulting ervices. The company was founded by Mark Sullivan in 2005 and is headquartered in Melbourne, Australia. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | 01.10.2005 | - | |
Gründer | 01.10.2005 | - | |
Adjuvant Capital LP
![]() Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | Private Equity Investor | 01.07.2020 | - |
Global Health Funds LLC | Berater | 01.12.2020 | - |
Karriereverlauf von Mark Sullivan
Ehemalige bekannte Positionen von Mark Sullivan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
OPTHEA LIMITED | Corporate Officer/Principal | 18.02.2011 | 15.12.2012 |
University of New South Wales Built Environment | Geschäftsführer | 01.03.2003 | 30.09.2005 |
GILEAD SCIENCES, INC. | Direktor/Vorstandsmitglied | 01.01.2001 | 31.12.2003 |
i3 Global
![]() i3 Global Miscellaneous Commercial ServicesCommercial Services i3 Global operates as a pharmaceutical services company. It offers therapeutically specialized contract research solutions, clinical data services, staffing solutions, pharmacovigilance and epidemiology solutions. The company was founded in 1988 and is headquartered in Bernards, NJ. | Direktor/Vorstandsmitglied | 01.11.1999 | 31.12.2000 |
Ausbildung von Mark Sullivan
Deakin University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Australien | 5 |
Operativ
Director/Board Member | 3 |
Corporate Officer/Principal | 1 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
OPTHEA LIMITED | Health Technology |
Private Unternehmen | 4 |
---|---|
i3 Global
![]() i3 Global Miscellaneous Commercial ServicesCommercial Services i3 Global operates as a pharmaceutical services company. It offers therapeutically specialized contract research solutions, clinical data services, staffing solutions, pharmacovigilance and epidemiology solutions. The company was founded in 1988 and is headquartered in Bernards, NJ. | Commercial Services |
Medicines Development for Global Health Ltd
![]() Medicines Development for Global Health Ltd Pharmaceuticals: MajorHealth Technology Medicines Development Ltd. engages in the development of medicines and vaccines. Its development programs include Moxidectin Program, Global Health Programs, and Consulting ervices. The company was founded by Mark Sullivan in 2005 and is headquartered in Melbourne, Australia. | Health Technology |
Adjuvant Capital LP
![]() Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | Finance |
Global Health Funds LLC |
- Börse
- Insiders
- Mark Sullivan
- Erfahrung